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Abstract: Background: A number of studies have demonstrated that receptor and co-receptor expression levels which 
may affect viral entry, promoting cervical HIV infection. The aim was to evaluate the expression levels of CCR5, CXCR4 
and DC-SIGN mRNA in a sample of heterosexually HIV infected Mexican women. 
Methods: We enrolled twenty-six HIV heterosexual infected women attending a local infectious diseases medical unit. 
RNA was isolated from the cervix and gene expression analysis was performed using real-time PCR. 
Results: Expression rates for mRNA of CCR5 (median 1.82; range 0.003–2934) were higher than those observed for 
CXCR4 (0.79; 0.0061–3312) and DC-SIGN (0.33; 0.006–532) receptors (p < 0.05). A high correlation was found between 
the mRNA expression levels of these three receptors (rs = 0.52 to 0.85, p < 0.01). 
Conclusion: Levels of expression of the tested chemokine receptors in the cervix are different from each other and also 
vary from woman to woman, and seem to support the suggestion that chemokine receptor expression in genital tissues 
may be playing a role in the HIV transmission. 
Keywords: AIDS, HIV-1, Mucosae, CCR5, CXCR4, DC-SIGN. 
BACKGROUND 
 The Acquired Immunodeficiency Syndrome (AIDS) is a 
serious public health problem worldwide with 33.4 million 
people currently living with the Human Immunodeficiency 
Virus (HIV) according to UNAIDS and WHO [1]. In 
Mexico, the number of persons living with HIV is estimated 
to be 200,000 [2]. Although HIV infection initially affected 
homosexual men, the virus is now spreading to a growing 
number of heterosexual individuals. The male-to-female 
ratio among HIV-1-infected people in Mexico is estimated to 
be 4.9:1 [3]. 
 A number of HIV-1 infected patients acquired the virus 
during heterosexual exposure where the virus binds to the 
CD4 receptor and other co-receptors present on immune 
cells of the genital mucosa [4, 5]. HIV infection is mediated  
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by a complex interaction between HIV envelope proteins and 
receptors on target cells, particularly CD4 receptors; 
however, expression of this molecule alone is not enough to 
establish the infection. It is well known that CCR5 and 
CXCR4 co-receptors are necessary for the virus entrance [6]. 
Viral strains that utilize CCR5 are classified as R5-tropic 
(which replaced the designation M-tropic), whereas those 
that utilize CXCR4 are termed X4-tropic (replacing the 
designation T-tropic) [7]. R5 variants have been suggested to 
be the predominant strains following sexual transmission [7, 
8]. Experimental evidence indicates that co-receptor 
expression levels have impact on the efficiency of viral entry 
and may affect the pathogenesis of the HIV-1 infection [7]. 
However, data from previous studies have shown differences 
in the chemokine receptor expression, which possibly 
indicate that the transmission of R5 variants may not be 
directly associated with the levels of CCR5 within the 
genital tract [9]. Another important factor in viral 
transmission is the C-type lectin DC-SIGN (Dendritic Cell – 
Specific ICAM-3 Grabbing Nonintegrin, CD-209), which 
plays a central role in the mucosal HIV-1 infection from 
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Dendritic cells (DCs) to T cells. DC-SIGN binds the 
glycoprotein 120 (gp120) with a high affinity and 
independently of the other receptors and then transmits 
virions to T lymphocytes using the physiological functions 
of the dendritic cells to gain access to the lymphoid tissues 
[10-12]. 
 Recently, the interest in HIV tropism has re-emerged due 
mainly to the generation of new promising antiretroviral 
drugs that target CCR5, CXCR4, and DC-SIGN. 
Unfortunately, information regarding the events immediately 
following the HIV-1 infection in humans is insufficient. 
Therefore, it is important to identify cellular and molecular 
factors of the host that may be contributing to HIV-1 
transmission, not only to understand the subjacent 
immunopathogenesis but also to obtain information that can 
be useful to develop strategies to prevent the infection [13]. 
The aim of this study was to evaluate the mRNA expression 
of CCR5 and CXCR4 co-receptors and of the DC-SIGN 
receptor in cervical biopsies in a case series of HIV-1 
heterosexually infected Mexican women. 
METHODS 
 Patients and sample collection. HIV-1 heterosexually 
infected women undergoing medical care at the “Dr. Juan I. 
Menchaca Unidad de Infectología” Hospital General 
Regional No. 45, Instituto Mexicano del Seguro Social in 
Guadalajara, Western Mexico, were eligible. Written 
informed consent was obtained from each patient, and the 
study was approved by the institutional research and ethics 
review board of the Hospital General Regional No. 45. 
Superficial cervical biopsies (probably containing 
transitional epithelium with some few endocervical glands) 
were taken from each patient and stored in 1 ml of RNA 
stabilization solution (RNAlater; Ambion, Austin, TX) at 
room temperature. Menstruating patients, those who engaged 
in sexual activity within 48 hours prior to sampling, those 
with symptoms of any known genital tract infection, and 
those with a history of intravenous drug use or blood 
transfusion were excluded. Women younger 48 years of age 
were classified as premenopausal, while those with 48 years 
old and over were considered postmenopausal [14]. 
 RNA isolation and cDNA synthesis. Cervical tissues 
were homogenized in 1 ml of TRIzol reagent (Invitrogen, 
Carlsbad, CA) and then processed following the 
manufacturer’s instructions. RNA isolate was eluted in 
RNase-free water treated with diethylpyrocarbonate (DEPC). 
RNA concentration was determined by the absorbance at 260 
nm. For synthesis of the single strand cDNA, SuperScript II 
Reverse Transcriptase (Invitrogen) and Oligo dT Primer 
(Invitrogen) were used. The reactions were adjusted to 5 μg 
of total RNA concentration, and were mixed with 1 μL of 10 
mM dNTP’s Mix (Amersham Biosciences, Piscataway, NJ). 
This was completed at a final volume of 12 μL with sterile 
Milli-Q water. Next, the mixture was heated at 65°C for 5 
min and then immediately chilled in an ice bath. In the 
second step of the reaction, 4 μL of the reaction solution (5x 
First Strand Buffer, Invitrogen) and 2 μL of DTT 0.1 M were 
added. This was maintained at 42° C for 2 min. Finally, 0.5 
μL of reverse transcriptase enzyme were added and the 
reaction was completed at a final volume of 20 μL with 
sterile Milli-Q water. The mix was incubated for 50 min at 
42° C and then for 15 min at 70° C to inactivate the reaction. 
 Real-time PCR. Receptor mRNA relative expression 
was measured with real-time PCR using the 2
C
T Livak 
method [15]. The relative expession of the target (HIV-
infected), normalized to an endougenous reference (18S 
rRNA) and controls (15 non–HIV-infected women), was 
obtained by 2
C
T, whereas CT was defined as the 
difference of CT (target) and CT (controls), and the CT was 
defined as the difference in CT (CCR5, CXCR4 or DC-SIGN) and the 
CT (endogenous reference) [16]. Serial dilutions from one of the 
samples were made to validate the efficiency of the 
quantitative PCR (qPCR) assay and were tested with the 
Taqman probes. The results were analyzed in a calibration 
curve considering that the regression value must be close to 
1 and the slope close to -3.32 [17]. All reactions were 
adjusted to a concentration of 10 ng. Double distilled water 
was used as a negative control. Ten microliters of the 
TaqMan Universal PCR master mix (Applied 
Biosystems/Roche, Foster City, CA) were mixed with 1 μL 
of the corresponding TaqMan assay. Reactions were 
completed at 20 μL total volume by adding double distilled 
water and were performed using the iCycler thermocycler 
(Bio-Rad, Hercules, CA) in the required settings for TaqMan 
assays. Primers and probes were designed based on the 
mRNA sequence, and the sequences were 5’-TGT AGA 
AGG AGA CAG AGC TGG TT-3’ for the forward primer, 
5’-GCC GTC AAG GTT CTT CAT GAT CTA G-3’ for the 
reverse primer and 6FAM-5’- CCT CCC CAT GTC TTC C-
3’-TAMRA fluorogenic probe for the CCR5 co-receptor. 5’-
GTT GTC TGA ACC CCA TCC TCT ATG-3’ forward, 5’-
CGT GCT GGG CAG AGG TTT TA-3’ reverse and 6FAM-
5’-AAT TTG GCT CCA AGG AAA G-3’-TAMRA probe 
for CXCR4; and for the DC-SIGN, 5’-GTC CCT CAG TGG 
AGC AAG TT-3’ forward, 5’-TTC GTT TCT CCT TCT 
TCA GGG C-3’ reverse and 6FAM-5’-CCT GCT GGC GTT 
TCT-3’- TAMRA probe. Each qPCR reaction was made in 
triplicate. 
 Statistical Analysis. Medians and ranges were used to 
describe the main results. The Kolmogorov–Smirnov test 
was used to evaluate the normality of variables. The non-
parametric Wilcoxon’s signed rank test and the Friedman’s 
analysis of variance (ANOVA) for repeated measures were 
used to compare expression levels between the evaluated co-
receptors. To compare expression of these co-receptors 
according to the HAART status of the patients the Mann–
Whitney U test and the Kruskal–Wallis’ ANOVA were used. 
The Spearman’s test was used to evaluate the correlation of 
the co-receptor expression levels with the VL and T CD4+ 
lymphocytes counts. Analysis was carried out using the 
SPSS version 15.0 (SPSS Inc., Chicago, IL, USA). A p value 
< 0.05 was considered statistically significant. 
RESULTS 
 Patient sample. Cervical biopsies from 26 HIV-1 
heterosexually infected women, 22 to 69 year old, were 
examined. All patients were asymptomatic and had been 
diagnosed with HIV-1 infection 1 to 13 years prior to 
enrollment. At the time of sampling, fourteen patients were 
on Highly Active Antiretroviral Therapy (HAART) and nine 
had a history of antiretroviral treatment. Most of these 
Expression of CCR5, CXCR4 and DC-SIGN The Open AIDS Journal, 2012, Volume 6    241 
patients had previously received or were receiving the 
combination of one protease inhibitor boosted with ritonavir 
plus two Nucleoside Reverse Transcriptase Inhibitors 
(NRTI). The other three patients had never received 
antiretroviral therapy. The viral load (VL) of most of the 
patients was under the detection level (<50 RNA copies/ml) 
with the exception of four patients whose VL was between 
1200 and 5600 copies/ml. Absolute CD4+ cell counts of all 
patients were above 200 /μl (Table 1). 
 Expression of CCR5, CXCR4 and DC-SIGN mRNA. 
Different expression levels were found for the three co-
receptor mRNAs evaluated in the cervical biopsies 
(p<0.0001). Expression of CCR5 (Ratio[test/calibrator] median 
1.82; range 0.003–2934) was higher than that observed for 
CXCR4 (0.79; 0.0061–3312) (p=0.025), and the expression 
of the former was in turn higher than that of the DC-SIGN 
receptor (0.33; 0.006–532) (p=0.046) (Fig. 1). A high 
positive correlation was observed between the expression 
levels of the three receptor-mRNAs evaluated (rs ranging 
from 0.52 to 0.85, p<0.01). No correlation was found 
between the expression levels of the three co-receptors 
evaluated with the CD4+ cell counts in blood (rs ranging 
from 0.104 to 0.155, p=NS), but we found a moderate 
correlation of the levels of plasma viral load with the 
expression of CCR5 (rs=0.41, p=0.04) and DC-SIGN 
(rs=0.40, p=0.04). On the other hand, we did not find any 
difference when expression levels of the three evaluated co-
receptor mRNAs were compared according to the HAART 
status. Thus, median and ranges of CCR5 levels were 1.76 
[0.02–759.42], 1.36 [0.00–2934.20] and 31.31 [0.04–98.27] 
for patients currently on HAART, previously on HAART 
and naïve, respectively (p=0.91). The expression levels of 
CXCR4 were 0.81 [0.01–696.39], 0.27 [0.01–3312.30] and 
6.69 [0.06–146.40] for the same groups of patients (p=0.87), 

























1 69 6 1 560 <50 Currently Abstention 
2 67 3 1 260 <50 Previously None 
3 41 4 1 200 1870 Currently Intrauterine device 
4 32 3 1 357 5600 Naïve Abstention 
5 36 11 1 421 <50 Previously Hormonal oral 
6 47 2 1 350 <50 Naïve None 
7 38 13 1 1200 <400 Currently Condom 
8 34 1 1 201 <50 Previously Hormonal oral 
9 38 8 1 258 <50 Previously Abstention 
10 26 10 1 445 <50 Currently Abstention 
11 40 2 2 360 <50 Currently Bilateral tubal occlusion 
12 48 9 1 560 <50 Currently None 
13 39 1 2 450 <50 Previously Abstention 
14 48 1 1 800 <50 Currently Abstention 
15 51 2 1 430 <50 Previously Condom 
16 48 6 1 208 1800 Previously Abstention 
17 51 3 1 798 <50 Currently None 
18 41 2 1 546 <50 Previously None 
19 46 1 1 452 <400 Currently Hormonal oral 
20 35 4 1 246 <50 Currently None 
21 27 1 1 450 <50 Previously None 
22 22 6 2 310 400 Currently Condom 
23 46 1 1 969 400 Previously Abstention 
24 29 3 1 300 1200 Naïve Abstention 
25 38 9 1 609 <50 Currently Abstention 
26 62 3 1 550 <400 Currently Hormonal oral  
aFrom the date of the HIV diagnosis in years. 
bPersonal information obtained through direct questioning. 
cAs the number of cells/mm3 of blood. 
dAs the number of RNA copies/ml of plasma using the COBAS Amplicor HIV-1 Monitor (Roche Diagnostics, Branchburg, NJ, USA). 
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while DC-SIGN levels were 0.32 [0.01–327.50], 0.27 [0.01–
532.36] and 8.61 [0.03–12.18] (p=0.94). No significant 
differences were found in the expression of the three 
receptors when we compared pre- and post-menopausal HIV 
infected patients; however, in pre-menopausal patients all of 
them were higher. Thus, median and ranges of CCR5 levels 
were 4.34 [0.00–2934.20] and 0.30[0.02–759.42] in pre-
menopausal and post-menopausal women, respectively 
(p=0.16). The expression levels of CXCR4 were 2.49 [0.01–
3312.60] and 0.26 [0.01–693.39] for the same groups of 
women (p=0.17) and for DC-SIGN 4.74 [0.01–532.36], and 
0.09 [0.01–327.70] (p=0.19). 
 
Fig. (1). Box and whisker plot of CCR5, CXCR4 and DC-SIGN 
receptor expression relative to receptor expression in uninfected 
women in cervical biopsies of 26 HIV-1 heterosexually infected 
Mexican women determined by the real-time PCR relative 
quantification scheme. Extreme values are hidden. 
DISCUSSION 
 The global spread of the HIV-1 infection has been 
achieved by sexual transmission through the genital tract and 
women seem to be at a higher risk than men are [18]. 
Infection of cells with HIV-1 in sexual contact sites requires 
an additional chemokine receptor and it has been suggested 
that CCR5 is the first receptor utilized, followed by CXCR4 
during advanced stages of the disease. Some studies have 
suggested that the higher expression of CCR5 may be the 
primary explanation for preferential transmission of CCR5-
tropic (R5) isolates within the genital tract; however, this 
concern is still controversial [9]. In this study, the expression 
levels of CCR5, CXCR4 and DC-SIGN co-receptor mRNA 
in cervical biopsies of HIV-1 infected Mexican women were 
evaluated. 
 In the present study, the expression of CCR5 mRNA was 
higher than that observed for CXCR4 or DC-SIGN. 
Patterson et al. [8] also found that the expression levels of 
CCR5 mRNA were significantly higher than the CXCR4 
levels in cervical biopsies obtained from five HIV infected 
patients. However, McClure et al. [9] evaluated cervical 
scrape samples obtained from a cohort of healthy women 
and reported that the expression of CCR5 was lower than 
that of CXCR4. This inconsistency could be due to 
differences in the evaluated patients and tissue sampling. In 
contrast to the McClure study, we did not evaluate healthy 
women. Our findings also differ from those reported by 
Zhang et al. [19] who, by immunohistochemical staining, 
found a high expression of CXCR4 in vaginal and cervical 
samples obtained from both women and macaques. Although 
in the present study immunohistochemical techniques were 
not used as Zhang et al. did, we used a more sensitive and 
well-accepted method to quantitatively evaluate mRNA 
expression levels of these co-receptors [20, 21]. 
 All patients included in the present study acquired HIV 
infection through sexual intercourse, the most common way 
of transmission. Sheffield et al. [22] showed increased 
numbers of CD4+ cells expressing CCR5 in biopsies 
obtained from genital ulcers and it is well known that this 
type of visible lesions on the cervical mucosa increases the 
risk of HIV transmission in women [22, 23]. We may 
exclude such lesions as an explanation for the observed 
levels of expression of the receptors evaluated because 
patients with genital ulcers were excluded from our study, 
however, we did not evaluate the expression levels of mRNA 
of these receptors on CD4+ cells alone, but on all cells of the 
endocervix. 
 A number of studies have shown that the menstrual cycle 
does not significantly affect the immune status of the genital 
tract [24-26], nevertheless, Howell et al. found that receptor 
and co-receptor expressions in the genital tract vary as a 
function of menstrual cycle stages [27]. Therefore, we 
excluded menstruating patients and those with recent vaginal 
intercourse to reduce the possibility of mucosal changes 
related to these events. Prakash et al. [28] demonstrated that 
the use of oral contraceptives is associated with an increased 
expression of CCR5 on CD4+ T endocervical lymphocytes, 
which may increase the susceptibility of these cells to HIV-1 
infection [29]. Although the microenvironment of the female 
genital tract may be altered by the use of oral contraceptives, 
it is highly unlikely that our findings were secondary to their 
use owing to a low percentage of our patients using them. 
Moreover, we did not find significant differences between 
the mRNA expression levels of the three co-receptors, but 
they tended to be higher in pre-menopausal women when 
compared with those of post-menopausal women. This 
suggests that the pre-menopausal women are at a higher risk 
of re-infection by sexual intercourse with HIV-1 infected 
partners, but further studies are needed to elucidate the role 
of the sex hormone status in modifying HIV receptors’ and 
co-receptors’ expression and changing the susceptibility of 
target cells to the HIV infection. 
 We found no significant differences in the expression 
levels of mRNA of the three receptors tested according to the 
antiretroviral treatment status. Previous studies have 
demonstrated an upregulation of CCR5 expression on 
several immune cells occurring early in the HIV infection 
that seems to provide a selective advantage to the virus but 
that is downregulated toward a normal expression by the 
antiretroviral therapy [30, 31]. The lack of differences we 
found might be attributed to the wide variability in the levels 
of expression observed which in turn might be due to the 
small number of patients evaluated. In the study by McClure 
et al. [9], a wide range of CXCR4 expression in the female 
ecto and endocervix was found but not for CCR5. 
 It has been demonstrated that in addition to the 
conventional binding of HIV to CD4 and the chemokine 
coreceptors (CCR5, CXCR4), HIV can interact with 
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adhesion molecules as DC-SIGN, complement receptors, Fc 
receptors, and heparan sulfate proteoglycans [32]. We 
observed a low expression of DC-SIGN in comparison with 
the other evaluated receptors in the genital tract of HIV-1 
heterosexually infected Mexican women. Approximately 1 
to 5% of the cells in the rectal mucosa express DC-SIGN 
[31], which may be related to the low expression levels of 
this receptor found in the cervix. Jameson et al. [13] detected 
cells expressing DC-SIGN receptors in the subepithelial 
lamina propia of the vagina and cervix, with a small 
proportion of these cells co-expressing CCR5 in the vagina 
but not in the cervix. This finding appears to be different 
from our results. Additionally, Gurney et al. [33] 
demonstrated that differences in the expression levels of DC-
SIGN, CCR5 and CXCR4 chemokine receptors might be 
relevant in the transfer of the virus from the peripheral to the 
secondary lymphoid organs or in supporting the local viral 
infection and replication. However, since the mechanisms 
involved in the mucosal HIV infection remain unresolved, 
new insights into the dynamics of these events are needed. 
 The contributing factors in the emergence of X4 variants 
in later stages of the HIV infection are unknown. Montfort et 
al. [34] reported that dendritic cells in mucosal sites do not 
easily transfer R5 viruses. The dendritic cells preferentially 
transfer X4 viruses to the CD4+ T lymphocytes in trans, an 
effect observed in cells expressing high levels of DC-SIGN 
receptors [34]. In this study, low levels of DC-SIGN 
expression in cervical biopsies of HIV heterosexually 
infected women were found, which might be related to the 
preferential transmission of R5 variants upon sexual contact. 
 In conclusion, our findings show that levels of expression 
in cervix of the evaluated chemokine receptors differ from 
one receptor to another and vary from woman to woman. In 
the cervical biopsies obtained from heterosexually HIV-1 
infected Mexican women, the expression of the CCR5 co-
receptor was higher than that of the CXCR4 and DC-SIGN. 
This finding seems to support the suggestion that the 
chemokine receptor expression may influence the 
transmission of R5 isolates. However, further studies 
evaluating cervical samples obtained from larger series of 
patients and, above all, cohorts of recently HIV-1 infected 
women followed over longer periods are needed before 
definitive conclusions about the actual role of these co-
receptors may be drawn. 
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